# OnCo record di-bella-multitherapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/di-bella-multitherapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "di-bella-multitherapy" ;
  schema:name "Di Bella multitherapy"@en ;
  schema:alternateName "Di Bella method"@en, "Di Bella regimen"@en, "Di Bella's tetralogy"@en, "DBM"@en ;
  schema:description "The Di Bella method combines somatostatin, melatonin, bromocriptine, retinoids and low-dose chemotherapy, and was hugely popular in Italy in the late 1990s. Eleven government-funded trials found no complete responses, a partial response rate under one per cent and considerable side effects."@en ;
  schema:url <https://onco.cc/technologies/di-bella-multitherapy/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/di-bella-multitherapy> ;
  onco:status "negative" ;
  onco:tag "complementary", "supportive-care", "evidence:no-benefit" ;
  onco:related <https://onco.cc/technologies/insulin-potentiation-therapy/>, <https://onco.cc/technologies/gonzalez-regimen/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/alternative-medicine-instead-of-treatment/>, <https://onco.cc/technologies/melatonin-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/hydroxyurea/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> .